Advertisement

Topics

Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology

08:53 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Seqirus, a leading innovator in influenza vaccines and pandemic preparedness, today announced the next major advancement in the use of cell-based technology at its state-of-the art manufacturing facility in Holly Springs, North ...

Other Sources for this Article

For Seqirus:
Nate Gilbraith, +1 612-455-1915
Nate.Gilbraith@padillaco.com
or
Kim Blake, +1 757-635-5658
kim.blake@padillaco.com

NEXT ARTICLE

More From BioPortfolio on "Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...